Fol. Biol. 2012, 58, 256-260
https://doi.org/10.14712/fb2012058060256
Acute Pancreatitis Is Associated with Ser608Leu iNOS Polymorphism
References
1. 1998) Increased nitric oxide activity in a rat model of acute pancreatitis. Gut 43, 564-570.
< , R. A., Williamson, R. C., Mathie, R. T. (https://doi.org/10.1136/gut.43.4.564>
2. 2007) The NOS3 (27-bp repeat, intron 4) polymorphism is associated with susceptibility to osteomyelitis. Nitric Oxide 16, 44-53.
< , V., Montes, A. H., Valle, E., Ocaña, M. G., Astudillo, A., Alvarez, V., López-Anglada, E., Solís, A., Coto, E., Meana, A., Gonzalez, P., Carton, J. A., Paz, J., Fierer, J., Celada, A. (https://doi.org/10.1016/j.niox.2006.06.005>
3. 2003) Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: Relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population. Am. J. Trop. Med. Hyg. 6, 569-573.
< , C. C. S., Hobbs, M. R., Marsh, R. L., Misukonis, M. A., Tkachuk, A. N., Lagog, M., Booth, J., Granger, D. L., Bockarie, M. J., Mgone, C. S., Levesque, M. C., Weinberg J. B., Anstey, N. M. (https://doi.org/10.4269/ajtmh.2003.69.569>
4. 1993) A clinically based classification system for acute pancreatitis. Arch. Surg. 128, 586-590.
< , E. L. (https://doi.org/10.1001/archsurg.1993.01420170122019>
5. 2008) Genetic polymorphisms in mediators of inflammation and gastric precancerous lesions. Eur. J. Cancer Prev. 17, 178-183.
< , F., Francechi, S., Plummer, M., van Doorn, L. J., Lu, Y., Gioia-Patricola, L., Vivas, J., Lopez, G., Severson, R. K., Schwartz, A. G., Munoz N., Kato, I. (https://doi.org/10.1097/CEJ.0b013e3282b6fd88>
6. 2010) A crucial role of nitric oxide in acute lung injury secondary to the acute necrotizing pancreatitis. Hum. Exp. Toxicol. 29, 329-337.
< , S., Yan, W. M., Yang, B., Shi, J., Song, M., Zhao, Y. (https://doi.org/10.1177/0960327110361760>
7. 1994) Nitric oxide contributes to multiorgan oxidative stress in acute experimental pancreatitis. Scand. J. Gastroenterol. 29, 943-948.
< , A., Gabryelewicz, A. (https://doi.org/10.3109/00365529409094868>
8. 1996) CYP2D6 multiallelism. Methods Enzymol. 272, 199-210.
< , A. K., Steen, V. M., Fairbrother, K. S., Idle, J. R. (https://doi.org/10.1016/S0076-6879(96)72024-4>
9. 2008) Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 17, 727-731.
< , H. R., Wild, C. P., Anderson, L. A., Murphy, S. J., Johnston, B. T., Murray, L. J., Watson, R. G., McGuigan, J., Reynolds, J. V., Hardie, L. J. (https://doi.org/10.1158/1055-9965.EPI-07-2570>
10. 2004) Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain. Rheumatology 43, 1182-1185.
< , M. A., Llorca, J., Sanchez, E., Lopez-Nevot, M. A., Amoli, M. M., Garcia-Porrua, C., Ollier W. E. R., Martin, J. (https://doi.org/10.1093/rheumatology/keh283>
11. 2008) Nitric oxide synthase genes and their interactions with environmental factors in Parkinson’s disease. Neurogenetics 9, 249-262.
< , D. B., Martin, E. R., Vance, J. M., Scott, W. K. (https://doi.org/10.1007/s10048-008-0137-1>
12. 2002) A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 360, 1468-1475.
< , M. R., Udhayakumar, V., Levesque, M. C., Booth, J., Roberts, J. M., Tkachuk, A. N., Pole, A., Coon, H., Kariuki, S., Nahlen, B. L., Mwaikambo, E. D., Lal, A. L., Granger, D. L., Anstey N. M., Weinberg, J. B. (https://doi.org/10.1016/S0140-6736(02)11474-7>
13. 2006) Analysis of the inducible nitric oxide synthase gene polymorphisms in Czech patients with atopic diseases. Clin. Exp. Allergy 36, 1592-1601.
< , L. I., Stejskalova, A., Znojil V., Vasku, A. (https://doi.org/10.1111/j.1365-2222.2006.02612.x>
14. 2000) No evidence for linkage in the promoter region of the inducible nitric oxide synthase gene (NOS2) in a Danish type 1 diabetes population. Genes Immun. 1, 362-366.
< , J., Pociot, F., Kristiansen, O. P., Karlsen A. E., Nerup, J. (https://doi.org/10.1038/sj.gene.6363686>
15. 2001) Linkage of the human inducible nitric oxide synthase gene to type I diabetes. J. Clin. Endocrinol. Metab. 86, 2792-2796.
, J., Pie, A., Pociot, F., Kristiansen, O. P., Karlsen A. E., Nerup, J. (
16. 2010) Gastriccancer is associated with NOS2-954G/C polymorphism and environmental factors in a Brazilian population. BMC Gastroenterol. 10, 64-71.
< , Y. C., Duarte, M. C., Silva, A. E. (https://doi.org/10.1186/1471-230X-10-64>
17. 1998) Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 351, 265-266.
< , J., Mordmuller, B., Lell, B., Lehman, L. G., Luckner D., Kremsner, P. G. (https://doi.org/10.1016/S0140-6736(05)78273-8>
18. 2009) Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis 30, 621-625.
< , K., Kang, D., Park, S. K., Berndt, S. I., Reding, D., Chatterjee, N., Chanock, S., Huang W. Y., Hayes, R. B. (https://doi.org/10.1093/carcin/bgp028>
19. 2008) A prospective cohort study of smoking in acute pancreatitis. Pancreatology 8, 63-70.
< , B., Appelros, S., Manjer, J., Berglund G., Borgstrom, A. (https://doi.org/10.1159/000114868>
20. 1995) Protective effect of nitric oxide on development of acute pancreatitis in rats. Dig. Dis. Sci. 40, 2162-2169.
< , X., Nakano, I., Yamaguchi, H., Yamaguchi, H., Ito, T., Goto, M., Koyanagi, S., Kinjoh M., Nawata. H. (https://doi.org/10.1007/BF02209000>
21. 2006) Association between achalasia and nitric oxide synthase gene polymorphisms. Am. J. Gastroenterol. 101, 1979-1984.
< , F., García-Gonzalez, M., Strunk, M., Zárate, N., Malagelada J. R., Lanas, A. (https://doi.org/10.1111/j.1572-0241.2006.00762.x>
22. 1993) The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329, 2002-2012.
, S., Higgs, A. (
23. 2002) Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes. J. Mol. Med. 80, 96-104.
< , J. B., Markus, M. A., Glenn, C. L., Adams, D. J., Colagiuri S., Wang, L. (https://doi.org/10.1007/s00109-001-0287-1>
24. 2011) Hypertonic saline and reduced peroxynitrite formation in experimental pancreatitis. Clinics 66, 469-476.
< , E. C. S., Moretti, A. S., Velasco, I. T., Souza, H. P., Abatepaulo, F., Soriano, F. (https://doi.org/10.1590/S1807-59322011000300019>
25. 2004) A novel genetic polymorphism of inducible nitric oxide synthase is associated with an increased risk of gastric cancer. World J. Gastroenterol. 10, 3278-3283.
< , J., Wang, R. T., Wang, L. W., Xu Y. C., Wang, X. R. (https://doi.org/10.3748/wjg.v10.i22.3278>
26. 1995) Vasoactive mediators and the progression from oedematous to necrotizing experimental acute pancreatitis. Gut 37, 434-440.
< , H., Lerch, M. M., Gress, T. M., Pfaff, D., Turi S., Adler, G. (https://doi.org/10.1136/gut.37.3.434>
27. 2006) Germline mutations and gene polymorphism associated with human pancreatitis. Endocrinol. Metab. Clin. North Am. 35, 289-302.
< , F. U., Simon, P., Mayerle, J., Kraft M., Lerch, M. M. (https://doi.org/10.1016/j.ecl.2006.02.001>